Form 4 for ICUI ICU MEDICAL INC/DE
Accepted 2024-08-30 00:00:00 ET · period of report 2024-08-30 · accession 0001698998-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-30 | 2024-08-30 | ICUI | Woolson Daniel | VP, GM-Infusion Capital | S - Sale | $163.22 | -2,502 | 13.1K | -16% | -$408.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | S | D | 2,502 | $163.22 | 13,107 | D | — | — | (F1) The sales price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $163.825, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full |